@FiercePharma: Supreme Court agrees to hear sales-rep overtime suit. Ruling promises to affect the whole industry-WSJ. News | Follow @FiercePharma
> China is gathering its forces for an assault on the global vaccine market, a move that could lower the cost of shots for poor countries--provided safety fears are assuaged. News
> BioMarin Pharmaceutical has won FDA approval for the expansion of its manufacturing facility in Novato, CA, where it makes Aldurazyme and Naglazyme. Item
> Citi's Yaron Werber lowered his price target on Vertex Pharmaceuticals ($VRTX) to $40 from $59, saying the company will face intense competition for its hepatitis C drug Incivek. Article
> Pozen ($POZN) now looks to a profit for 2011 as $75 million migraine-drug rights sale will be booked as revenue. Story
> The Canadian province of Manitoba has added Pfizer's ($PFE) stop-smoking drug Champix (sold as Chantix in the U.S.) to the health system formulary. More
Biotech News
@FierceBiotech: Onyx Pharma shares soar on report of its hunt for options, acquirers. Story | Follow @FierceBiotech
@RyanMFierce: Roche inked a deal with PTC for Spinal Muscular Atrophy program, $30M upfront and $460M in biobucks. | Follow @RyanMFierce
@MaureenFierce: China prepares for big entry into vaccine market. Will be game-changer if China can alleviate safety concerns. Report | Follow @MaureenFierce
> Onyx Pharma shares soar on report of its hunt for options, acquirers. News
> Roche, PTC strike potential $490M deal for genetic disease program. Article
> 22 drugs to watch in 2012. Report
Research News
> Neuron implants fix broken brain circuitry in obese mice. News
> Combo drug offers potent weapon against radiation exposure. Story
> Princeton research could speed pharma discoveries. More
> New target discovered in battle against lymphoma. Piece
Manufacturing News
> McKesson, J&J eye GHX platform for e-pedigree. Item
> Hospira to spend $375M in manufacturing upgrades. Report
> Europe takes precautions with Ben Venue drugs. News
> Ranbaxy, FDA near $400M deal on longstanding violations. Story
> McKesson, J&J eye GHX platform for e-pedigree. Article
And Finally... Vaccinating children more than a year old against chickenpox offers 'tremendous indirect benefits' to infants, researchers said. Report